Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Indocyanine Green × Clear all

Phase

Status

Completed 5 Terminated 2 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Neoplasms 3 Stomach Neoplasms 2 Sarcoma 2 Lymphatic Metastasis 2 Lung Neoplasms 2 Giant Cell Tumor of Bone 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma, Ewing 1 Right Hemicolectomy 1 Rhabdomyosarcoma 1 Parathyroid Diseases 1 Osteosarcoma 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Giant Cell Tumor of Tendon Sheath 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Breast Cancer Lymphedema 1

Interventions

pembrolizumab 23 Paclitaxel 19 Carboplatin 17 Specimen Handling 12 Bevacizumab 11 Letrozole 10 dostarlimab 7 Magnetic Resonance Spectroscopy 7 Biopsy 7 abemaciclib 6 Taxes 6 Fulvestrant 6 Megestrol Acetate 5 Medroxyprogesterone Acetate 5 Cisplatin 5 Blood Specimen Collection 5 trastuzumab deruxtecan 4 olaparib 4 Observation 4 Immunoglobulin G 4 Drug Therapy 4 Doxorubicin 4 palbociclib 3 lenvatinib 3 atezolizumab 3 X-Rays 3 Radiotherapy 3 Progestins 3 Nivolumab 3 Gemcitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04845828 2022-02-21

SELYE

Asan Medical Center

Phase NA Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡